Medical Marijuana Inc. Sees Growth Opportunities For Its Portfolio Company with Historic Washington 502 Vote to Legalize

  Medical Marijuana Inc. Sees Growth Opportunities For Its Portfolio Company
with Historic Washington 502 Vote to Legalize Marijuana for Recreational Use,
     Massachusetts New Medical Marijuana Initiative and Michigan Vote to
                 Decriminalize Marijuana in Four Major Cities

PR Newswire

SAN DIEGO, Nov. 7, 2012

SAN DIEGO, Nov. 7, 2012 /PRNewswire/ --Medical Marijuana Inc. (OTC: MJNA),a
leading hemp industry innovator, commends the millions of Washington voters
who helped pass Initiative 502 in the November 6 elections by a vote of 55
percent. The vote marks a historic landmark for the medical marijuana
industry, as Washington is now the second state in the U.S. to legalize
recreational marijuana use for adults over 21.

The Seattle Times reports that this legalization could help bring in hundreds
of millions of dollars a year in medical marijuana taxes, reduce small-time
pot-related arrests and give supporters a chance to show whether
decriminalization is a viable strategy in the war on drugs. It also reports
that 502 legalizes possession of up to an ounce beginning Dec. 6, with sales
at state-licensed stores at least a year away. According to The Associated
Press, Washington's measure will establish a system of state-licensed
marijuana growers, processors and stores that adults can visit to buy up to an
ounce and will also initiate a blood test limit for driving under the

The Washington measure was particularly notable for crossing partisan
boundaries, as well as for its high level sponsors and supporters who ranged
from public health experts and wealthy high-tech executives, to two former top
Justice Department's officials in Seattle. The effort raised more than $6
million in contributions, with more than $2 million of that coming from
Progressive Insurance Co. founder Peter Lewis, who used marijuana to treat
pain from a leg amputation, reports The Seattle Times.

In addition to the historic vote in Washington, Massachusetts voters also won
in yesterday's election by 58 percent to approve their Medical Marijuana
Initiative, which will, for the first time, provide Massachusetts patients
with certain medical conditions access to medical marijuana and eliminate
state criminal and civil penalties for these patients. The November 6 election
also proved groundbreaking for four major cities in Michigan- Detroit, Grand
Rapids, Flint and Ypsilanti. More than a million voters in these areas came
together to turn out a "yes" vote on amending their laws to decriminalize
marijuana possession for adults.

"It sets up a clear and obvious challenge with the federal government," said
Allen St. Pierre, executive director of NORML, which has fought for years to
legalize cannabis. Paul Armentano, deputy director of (NORML), also noted:
"Today, a majority of Americans espouse ending America's nearly century-long,
failed experiment with cannabis prohibition and replacing it with a system of
limited legalization and regulation." Ethan Nadelmann of the Drug Policy
Alliance, which opposes the so-called "war on drugs," points out that
"Marijuana policy reform remains an issue where the people lead and the
politicians follow…Washington state shows that many politicians are beginning
to catch up."

The decision to pass these historic laws opens the doors for MJNA portfolio
companies, such as Red Dice Holdings, to develop future product expansion
through licensing agreements with legal distributors for products like its
Dixie Elixirs & Edibles brand, which is already known as the leading brand of
edibles supplying most of the 500 plus dispensaries in Colorado. 

Seattle Times-State financial experts estimate the new legalization could
raise nearly $2 billion in tax revenue over the next five years, with the
money going toward education, health care, substance abuse prevention and
basic government services.

"We are thrilled that voters in Washington have joined Colorado in making
history as the second U.S. state to legalize recreational marijuana. We would
also like to congratulate Massachusetts voters for their commendable work in
legalizing medical marijuana for the first time, and Michigan voters for their
efforts to decriminalize its possession in four cities in the state. We look
forward to developing future manufacturing and distribution agreements with
qualified partners in Washington and MA," said Tripp Keber, President of Red
Dice Holdings.

It is important to note that although these legislative victories are a
milestone for all industrial hemp and medical marijuana advocates, their
outcome will not impact the future corporate strategy of MJNA. As a company,
MJNA continues to primarily focus on hemp oil, derived from seed and stalk,
with a strong concentration on the cannabinoid, CBD (cannabidiol).

"This decision marks quite an exciting achievement for the medical marijuana
industry. For MJNA, the legalization in Washington, decriminalization in four
cities in Michigan and new medical marijuana law in Massachusetts will open
new business opportunities and licensing partnerships for our portfolio
companies, as well as bring awareness and acceptance to the industry in
general. That is surely a benefit to us as we continue to focus our main
attention on branding our Hemp-based products," says Ted Caligiuri, President
and CEO of Medical Marijuana, Inc.

About Medical Marijuana,Inc.

Our mission is to be the premier hemp industry innovators, leveraging our team
of professionals to source, evaluate and purchase value-added companies and
products, while allowing them to keep their integrity and entrepreneurial
spirit. We strive to create awareness within our industry, develop
environmentally friendly, economically sustainable businesses, while
increasing shareholder value.

Medical Marijuana Inc. does not grow, sell or distribute any substances that
violate United States Law or the controlled substance act.

For more information, please visit the company's website at:

These statements have not been evaluated by the Food and Drug Administration
(FDA). These products and statements are not intended to diagnose, treat,
cure, or prevent any disease.


This press release may contain certain forward-looking statements and
information, as defined within the meaning of Section 27A of the Securities
Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is
subject to the Safe Harbor created by those sections. This material contains
statements about expected future events and/or financial results that are
forward-looking in nature and subject to risks and uncertainties. Such
forward-looking statements by definition involve risks, uncertainties and
other factors, which may cause the actual results, performance or achievements
of Medical Marijuana, Inc. to be materially different from the statements made

Corporate Contact:

Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)

Investor Relations Contact:
Stuart T. Smith
SmallCapVoice.Com, Inc.
P. 512-267-2430
F. 512-267-2530

SOURCE Medical Marijuana Inc.

Press spacebar to pause and continue. Press esc to stop.